Michael G Crooks
Overview
Explore the profile of Michael G Crooks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
616
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
den Brinker A, Ouweltjes O, Rietman R, Thackray-Nocera S, Crooks M, Morice A
Sensors (Basel)
. 2025 Jan;
25(2).
PMID: 39860774
Coughing is a symptom of many respiratory diseases. An increased amount of coughs may signal an (upcoming) health issue, while a decreasing amount of coughs may indicate an improved health...
2.
Hutchinson A, Russell R, Cummings H, Usmani O, MacFadyen S, Cohen J, et al.
BJGP Open
. 2024 Nov;
PMID: 39608799
Background: Chronic Obstructive Pulmonary Disease (COPD) exacerbations are clinically significant events that affect millions globally. Aim: To explore patients' and carers' experiences, understandings and responses to exacerbations. Design & Setting:...
3.
4.
Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis
Fraser S, Thackray-Nocera S, Wright C, Flockton R, James S, Crooks M, et al.
Lung
. 2024 Sep;
202(5):683-693.
PMID: 39284999
Introduction: In sarcoidosis granulomas, monocyte-derived macrophages are activated by pro-inflammatory cytokines including TNF and IL-6. Current drug treatment for sarcoidosis aims to suppress inflammation but disabling side effects can ensue....
5.
Wang H, Doran T, Crooks M, Khunti K, Heightman M, Gonzalez-Izquierdo A, et al.
J Infect
. 2024 Aug;
89(4):106235.
PMID: 39121972
Objectives: This study examines clinically confirmed long-COVID symptoms and diagnosis among individuals with COVID in England, aiming to understand prevalence and associated risk factors using electronic health records. To further...
6.
Sykes D, Mason P, Rahunathan N, Hart S, Morice A, Crooks M
Lung
. 2024 Jul;
202(5):569-579.
PMID: 38990397
Introduction: Azithromycin is an effective treatment for various respiratory conditions but its effect on cough is poorly understood. We synthesised data from randomised controlled trials (RCTs) and noncomparative studies (NCT)...
7.
van der Feltz-Cornelis C, Sweetman J, Turk F, Allsopp G, Gabbay M, Khunti K, et al.
Sci Rep
. 2024 Jun;
14(1):13634.
PMID: 38871773
The importance of integrated care for complex, multiple long term conditions was acknowledged before the COVID pandemic but remained a challenge. The pandemic and consequent development of Long COVID required...
8.
Monk P, Brookes J, Tear V, Batten T, Newall C, Mankowski M, et al.
Respir Res
. 2024 May;
25(1):228.
PMID: 38811970
Background: Respiratory viral infections are major drivers of chronic obstructive pulmonary disease (COPD) exacerbations. Interferon-β is naturally produced in response to viral infection, limiting replication. This exploratory study aimed to...
9.
Sykes D, See Y, Chow E, Crooks M, Cummings H, Robinson M, et al.
J Asthma
. 2024 Feb;
61(9):970-975.
PMID: 38323583
Introduction: One of the fundamental challenges of managing patients with severe asthma is treatment adherence, particularly with inhaled corticosteroids. Adherence is difficult to measure objectively and poor adherence is associated...
10.
A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy
Levy M, Beasley R, Bostock B, Capstick T, Crooks M, Fleming L, et al.
Br J Gen Pract
. 2024 Jan;
74(739):86-89.
PMID: 38272684
No abstract available.